Feussner G[Author] - Search Results

Year	Number of Results
1977	1
1979	4
1981	2
1982	2
1983	1
1987	1
1988	1
1989	2
1990	4
1991	3
1992	6
1993	4
1994	6
1995	3
1996	7
1997	2
1998	4
1999	1
2000	2
2002	2
2003	1
2021	0

1

HMG CoA reductase inhibitors.

Feussner G. Feussner G. Curr Opin Lipidol. 1994 Feb;5(1):59-68. doi: 10.1097/00041433-199402000-00010. Curr Opin Lipidol. 1994. PMID: 15559032 Review.

2

Type III hyperlipoproteinemia in a child with hemolytic uremic syndrome.

Feussner G, Wingen AM, Ziegler R. Feussner G, et al. Metabolism. 1990 Nov;39(11):1196-9. doi: 10.1016/0026-0495(90)90094-s. Metabolism. 1990. PMID: 2233282 Review.

3

Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels.

Larson IA, Ordovas JM, Barnard JR, Hoffmann MM, Feussner G, Lamon-Fava S, Schaefer EJ. Larson IA, et al. Among authors: feussner g. Clin Genet. 2002 Mar;61(3):176-84. doi: 10.1034/j.1399-0004.2002.610302.x. Clin Genet. 2002. PMID: 12000358

4

Genetics of type III hyperlipoproteinemia.

Feussner G, Piesch S, Dobmeyer J, Fischer C. Feussner G, et al. Genet Epidemiol. 1997;14(3):283-97. doi: 10.1002/(SICI)1098-2272(1997)14:3<283::AID-GEPI6>3.0.CO;2-6. Genet Epidemiol. 1997. PMID: 9181357

5

Molecular basis of type III hyperlipoproteinemia in Germany.

Feussner G, Feussner V, Hoffmann MM, Lohrmann J, Wieland H, März W. Feussner G, et al. Hum Mutat. 1998;11(6):417-23. doi: 10.1002/(SICI)1098-1004(1998)11:6<417::AID-HUMU1>3.0.CO;2-5. Hum Mutat. 1998. PMID: 9603433

6

Metabolism in the hamster brain during hibernation and arousal.

Lust WD, Wheaton AB, Feussner G, Passonneau J. Lust WD, et al. Among authors: feussner g. Brain Res. 1989 Jun 5;489(1):12-20. doi: 10.1016/0006-8993(89)90003-6. Brain Res. 1989. PMID: 2743144

7

Effects of apolipoprotein A-IV genotype on glucose and plasma lipoprotein levels.

Larson IA, Ordovas JM, Sun Z, Barnard, Lohrmann J, Feussner G, Lamon-Fava S, Schaefer EJ. Larson IA, et al. Among authors: feussner g. Clin Genet. 2002 Jun;61(6):430-6. doi: 10.1034/j.1399-0004.2002.610606.x. Clin Genet. 2002. PMID: 12121350

8

Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects.

Kinscherf R, Cafaltzis K, Röder F, Hildebrandt W, Edler L, Deigner HP, Breitkreutz R, Feussner G, Kreuzer J, Werle E, Michel G, Metz J, Dröge W. Kinscherf R, et al. Among authors: feussner g. Free Radic Biol Med. 2003 Nov 15;35(10):1286-92. doi: 10.1016/j.freeradbiomed.2003.07.001. Free Radic Biol Med. 2003. PMID: 14607527

9

Serum amyloid A protein (SAA): a marker for liver allograft rejection in humans.

Feussner G, Stech C, Dobmeyer J, Schaefer H, Otto G, Ziegler R. Feussner G, et al. Clin Investig. 1994 Dec;72(12):1007-11. doi: 10.1007/BF00577745. Clin Investig. 1994. PMID: 7711405

10

Association of apolipoprotein (Apo)E genotype with plasma apo E levels.

Larson IA, Ordovas JM, DeLuca C, Barnard JR, Feussner G, Schaefer EJ. Larson IA, et al. Among authors: feussner g. Atherosclerosis. 2000 Feb;148(2):327-35. doi: 10.1016/s0021-9150(99)00280-4. Atherosclerosis. 2000. PMID: 10657569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results